KYOCERA to Increase Annual Solar Cell Production Targets by March 2013

Kyocera Corporation (NYSE:KYO)(TOKYO:6971) today announced that it will increase its annual solar cell production targets to meet the growing demand for solar energy products in the global market. New targets aim for an incremental increase to 1 gigawatt (GW) per year by March 2013 — 2.5 times more than the current fiscal year 2010 production volume of 400MW.

Fiscal Year  Annual Solar Cell Production Plan


                                                        Previous     Revised


                                  2010              400MW     400MW


                                  2011              550MW     600MW


                                  2012              650MW     800MW


                                  2013                  ¯          1GW (1,000MW)


Fiscal years run from the preceding April 1 to March 31 of the indicated year.

As part of the new plan to increase annual cell production, Kyocera has recently completed construction of a new cell manufacturing plant in Yasu City, Shiga Prefecture, Japan which will operate in addition to the company's existing Shiga Yohkaichi Plant.

In response to growing demand Kyocera has established local production and supply networks for solar modules in North America, Europe, Japan and China — the world's four largest solar energy markets. In addition to the solar cell production increase, the company will continue to enhance its module assembly capability.

"Kyocera will continue to contribute to solving increasing environmental issues by providing solar panels with high quality and high reliability for the creation of clean energy," stated Tetsuo Kuba, president of Kyocera Corporation.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.